Delivery Order SPE2DR25D2005-SPE2DR26FE8L3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,869.09 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Briviact 50 mg tablets (60-count). This competitively awarded, firm fixed-price contract requires delivery by November 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $9,077.52 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply) on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $5,579.94 delivery order to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,793.15 delivery order on August 18, 2025, for Briviact 75 mg tablets (60-count units) through a firm fixed-price contract with an ultimate completion date of August 19, 2025. The award is non-set-aside and competitively awarded, with performance to take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,833.23 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,451.23 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Briviact 50 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,320.35 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply) on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $5,394.54 delivery order to AmerisourceBergen Drug Corp for Briviact 100mg tablets (60 count) on December 4, 2025, with completion expected by December 5, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical product shipment to support federal medical supply needs. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE8L3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,353.84 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply). This firm fixed price delivery order, awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement extending through December 2026 that serves as the company's primary vehicle for supplying pharmaceuticals and medical commodities to support military healthcare worldwide. AmerisourceBergen's substantial federal contract portfolio demonstrates its role as a critical pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and broader Department of Defense medical supply chains, delivering a comprehensive range of brand-name and generic medications across multiple therapeutic domains to support military personnel and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/8/25 |